Tato webová stránka používá cookies, které nám pomáhají při zlepšování stránek, a také přispívají k jejich jednoduššímu používání.
Tímto vyjadřujete souhlas s používáním cookies na našich stránkách. Přečtěte si více

You appear to be from the USA. Would like to proceed to Products available in the USA?

Updated guideline on Clostridium difficile infection

Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) recently updated the 2010 published clinical practice guideline on Clostridium difficile infection (CDI). The update includes significant changes in the management of this infection and reflects the evolving controversy over best methods for diagnosis. The updated guideline recommend molecular diagnostics (NAAT) for diagnosing Clostridium difficile from patients likely to have CDI based on clinical symptoms.

Read the Guideline:

Orion GenRead® C. difficile

Make the most of your resources

Orion GenRead C. difficile offers a reliable detection of toxigenic Clostridium difficile from faecal samples from patients suspected of having (CDI). With the easy to use portable NAAT system results are available in less than one hour meeting the need for rapid C. difficile testing in various healthcare settings. Read more: Orion GenRead C. difficile